The vascular access devices market size has grown strongly in recent years. It will grow from $6.11 billion in 2025 to $6.51 billion in 2026 at a compound annual growth rate (CAGR) of 6.6%. The growth in the historic period can be attributed to rising prevalence of chronic diseases requiring long term infusion therapy, growth in hospital and clinic based intravenous procedures, increasing utilization of central venous catheters and picc lines, expanding use of vascular access devices in diagnostics and blood transfusion, rising demand for peripheral iv catheters in acute care settings.
The vascular access devices market size is expected to see strong growth in the next few years. It will grow to $8.38 billion in 2030 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to growing preference for minimally invasive and patient friendly venous access solutions, increasing adoption of implantable ports for oncology and long duration therapies, expansion of vascular access services in ambulatory care centers, rising procedural volumes in drug and nutrition administration, increasing investments in safer catheter designs to reduce complications. Major trends in the forecast period include rising clinical adoption of long-term vascular access devices for chronic disease management, increasing demand for vascular access products that reduce repeated needle punctures, growing utilization of specialized catheters for chemotherapy, infusion therapy, and blood administration, expanding procedural volumes in hospitals and ambulatory care centers requiring reliable venous access, increasing emphasis on product designs enhancing patient comfort and procedural safety.
The growing prevalence of lifestyle diseases is expected to drive the growth of the vascular access devices market. Lifestyle diseases, also called non-communicable or chronic diseases, are primarily caused by unhealthy behaviors and habits rather than infectious agents. These conditions often require long-term treatment and care, making vascular access devices crucial for the safe and effective delivery of medications and therapies. For instance, in July 2025, according to the International Diabetes Federation, a Brussels-based international non-profit, approximately 589 million adults aged 20-79 are living with diabetes worldwide. By 2050, this number is projected to rise to 853 million, representing a 46% increase from current levels. Therefore, the rising prevalence of lifestyle diseases is propelling the vascular access devices market.
Companies in this market are focusing on innovations such as TipTracker technology to improve device efficiency and patient care. TipTracker technology provides real-time visual navigation by tracing the catheter pathway on a color screen, helping confirm final tip placement. For example, in May 2023, Teleflex Incorporated, a US-based medical device manufacturer, launched two new devices, the VPS Rhythm and DLX Device, incorporating TipTracker technology. This eliminates the need for confirmatory X-rays, streamlines peripherally inserted central catheter (PICC) insertion, and ensures proper advancement into the superior vena cava (SVC). These innovations enhance patient care, expand treatment options, and improve procedural efficiency.
In June 2025, Teleflex Incorporated acquired BIOTRONIK’s Vascular Intervention business for approximately $791 million in cash. This acquisition strengthens Teleflex’s global presence in catheterization labs, broadens its suite of vascular access and intervention technologies, and reinforces its position in peripheral vascular intervention procedures. BIOTRONIK’s Vascular Intervention division, based in Germany, specializes in drug-coated balloons, drug-eluting stents, balloon catheters, and other vascular access and intervention technologies.
Major companies operating in the vascular access devices market are Medtronic plc, Fresenius Medical Care AG & Co. KGaA, Becton Dickinson and Company (BD), Baxter International Inc., Boston Scientific Corporation, Medline Industries LP, Terumo Corporation, B. Braun Melsungen AG, Teleflex Incorporated, ICU Medical Inc., Cook Medical, Merit Medical Systems Inc., AngioDynamics Inc., Argon Medical Devices Inc., Nipro Medical Corporation, pfm medical ag, Amecath Medical Technologies, Romsons Group, Medical Components Inc., Access Vascular Inc., Newtech Medical Devices Pvt. Ltd., Vygon USA.
North America was the largest region in the vascular access devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the vascular access devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the vascular access devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are affecting the vascular access devices market by increasing the import and component costs of catheters, implantable ports, tubing materials, and precision connectors, leading to higher procurement and production expenses for hospitals, clinics, and ambulatory care centers. The impact is more significant in central vascular access devices and implantable port systems, particularly across regions that rely heavily on cross-border sourcing in North America, Europe, and Asia-Pacific. While tariffs create pricing pressure and longer supply cycles, they are also encouraging manufacturers to localize production, develop regional assembly capabilities, and optimize cost-efficient material sourcing, which supports long-term supply stability and competitive product development.
The vascular access devices market research report is one of a series of new reports that provides vascular access devices market statistics, including vascular access devices industry global market size, regional shares, competitors with a vascular access devices market share, detailed vascular access devices market segments, market trends and opportunities, and any further data you may need to thrive in the vascular access devices industry. This vascular access devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Vascular access devices (VADs) are medical instruments that facilitate entry to the bloodstream for multiple purposes, such as administering drugs, delivering fluids or blood products, and conducting diagnostic tests. These devices are employed to eliminate the necessity for frequent needle punctures in patients, offering increased convenience for both healthcare providers and patients.
The primary categories of vascular access devices exist are central vascular access devices and peripheral vascular access devices. Central vascular access devices are specialized medical tools designed to introduce catheters into larger veins, typically situated in proximity to the body's center. They find applications in drug administration, fluid and nutrition delivery, blood transfusions, and diagnostic testing across various end-users, including hospitals, clinics, ambulatory care centers, and others.
The vascular access devices market consists of sales of peripheral intravenous (IV) catheters, implanted ports, infusion pumps, ultrasound and X-ray equipment, and catheter removal kits. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The vascular access devices market size is expected to see strong growth in the next few years. It will grow to $8.38 billion in 2030 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to growing preference for minimally invasive and patient friendly venous access solutions, increasing adoption of implantable ports for oncology and long duration therapies, expansion of vascular access services in ambulatory care centers, rising procedural volumes in drug and nutrition administration, increasing investments in safer catheter designs to reduce complications. Major trends in the forecast period include rising clinical adoption of long-term vascular access devices for chronic disease management, increasing demand for vascular access products that reduce repeated needle punctures, growing utilization of specialized catheters for chemotherapy, infusion therapy, and blood administration, expanding procedural volumes in hospitals and ambulatory care centers requiring reliable venous access, increasing emphasis on product designs enhancing patient comfort and procedural safety.
The growing prevalence of lifestyle diseases is expected to drive the growth of the vascular access devices market. Lifestyle diseases, also called non-communicable or chronic diseases, are primarily caused by unhealthy behaviors and habits rather than infectious agents. These conditions often require long-term treatment and care, making vascular access devices crucial for the safe and effective delivery of medications and therapies. For instance, in July 2025, according to the International Diabetes Federation, a Brussels-based international non-profit, approximately 589 million adults aged 20-79 are living with diabetes worldwide. By 2050, this number is projected to rise to 853 million, representing a 46% increase from current levels. Therefore, the rising prevalence of lifestyle diseases is propelling the vascular access devices market.
Companies in this market are focusing on innovations such as TipTracker technology to improve device efficiency and patient care. TipTracker technology provides real-time visual navigation by tracing the catheter pathway on a color screen, helping confirm final tip placement. For example, in May 2023, Teleflex Incorporated, a US-based medical device manufacturer, launched two new devices, the VPS Rhythm and DLX Device, incorporating TipTracker technology. This eliminates the need for confirmatory X-rays, streamlines peripherally inserted central catheter (PICC) insertion, and ensures proper advancement into the superior vena cava (SVC). These innovations enhance patient care, expand treatment options, and improve procedural efficiency.
In June 2025, Teleflex Incorporated acquired BIOTRONIK’s Vascular Intervention business for approximately $791 million in cash. This acquisition strengthens Teleflex’s global presence in catheterization labs, broadens its suite of vascular access and intervention technologies, and reinforces its position in peripheral vascular intervention procedures. BIOTRONIK’s Vascular Intervention division, based in Germany, specializes in drug-coated balloons, drug-eluting stents, balloon catheters, and other vascular access and intervention technologies.
Major companies operating in the vascular access devices market are Medtronic plc, Fresenius Medical Care AG & Co. KGaA, Becton Dickinson and Company (BD), Baxter International Inc., Boston Scientific Corporation, Medline Industries LP, Terumo Corporation, B. Braun Melsungen AG, Teleflex Incorporated, ICU Medical Inc., Cook Medical, Merit Medical Systems Inc., AngioDynamics Inc., Argon Medical Devices Inc., Nipro Medical Corporation, pfm medical ag, Amecath Medical Technologies, Romsons Group, Medical Components Inc., Access Vascular Inc., Newtech Medical Devices Pvt. Ltd., Vygon USA.
North America was the largest region in the vascular access devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the vascular access devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the vascular access devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are affecting the vascular access devices market by increasing the import and component costs of catheters, implantable ports, tubing materials, and precision connectors, leading to higher procurement and production expenses for hospitals, clinics, and ambulatory care centers. The impact is more significant in central vascular access devices and implantable port systems, particularly across regions that rely heavily on cross-border sourcing in North America, Europe, and Asia-Pacific. While tariffs create pricing pressure and longer supply cycles, they are also encouraging manufacturers to localize production, develop regional assembly capabilities, and optimize cost-efficient material sourcing, which supports long-term supply stability and competitive product development.
The vascular access devices market research report is one of a series of new reports that provides vascular access devices market statistics, including vascular access devices industry global market size, regional shares, competitors with a vascular access devices market share, detailed vascular access devices market segments, market trends and opportunities, and any further data you may need to thrive in the vascular access devices industry. This vascular access devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Vascular access devices (VADs) are medical instruments that facilitate entry to the bloodstream for multiple purposes, such as administering drugs, delivering fluids or blood products, and conducting diagnostic tests. These devices are employed to eliminate the necessity for frequent needle punctures in patients, offering increased convenience for both healthcare providers and patients.
The primary categories of vascular access devices exist are central vascular access devices and peripheral vascular access devices. Central vascular access devices are specialized medical tools designed to introduce catheters into larger veins, typically situated in proximity to the body's center. They find applications in drug administration, fluid and nutrition delivery, blood transfusions, and diagnostic testing across various end-users, including hospitals, clinics, ambulatory care centers, and others.
The vascular access devices market consists of sales of peripheral intravenous (IV) catheters, implanted ports, infusion pumps, ultrasound and X-ray equipment, and catheter removal kits. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Vascular Access Devices Market Characteristics
3. Vascular Access Devices Market Supply Chain Analysis
4. Global Vascular Access Devices Market Trends and Strategies
5. Vascular Access Devices Market Analysis of End Use Industries
7. Global Vascular Access Devices Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Vascular Access Devices Total Addressable Market (TAM) Analysis for the Market
9. Vascular Access Devices Market Segmentation
10. Vascular Access Devices Market Regional and Country Analysis
11. Asia-Pacific Vascular Access Devices Market
12. China Vascular Access Devices Market
13. India Vascular Access Devices Market
14. Japan Vascular Access Devices Market
15. Australia Vascular Access Devices Market
16. Indonesia Vascular Access Devices Market
17. South Korea Vascular Access Devices Market
18. Taiwan Vascular Access Devices Market
19. South East Asia Vascular Access Devices Market
20. Western Europe Vascular Access Devices Market
21. UK Vascular Access Devices Market
22. Germany Vascular Access Devices Market
23. France Vascular Access Devices Market
24. Italy Vascular Access Devices Market
25. Spain Vascular Access Devices Market
26. Eastern Europe Vascular Access Devices Market
27. Russia Vascular Access Devices Market
28. North America Vascular Access Devices Market
29. USA Vascular Access Devices Market
30. Canada Vascular Access Devices Market
31. South America Vascular Access Devices Market
32. Brazil Vascular Access Devices Market
33. Middle East Vascular Access Devices Market
34. Africa Vascular Access Devices Market
36. Vascular Access Devices Market Competitive Landscape and Company Profiles
37. Vascular Access Devices Market Other Major and Innovative Companies
40. Vascular Access Devices Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Vascular Access Devices Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses vascular access devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for vascular access devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The vascular access devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Device Type: Central Vascular Access Devices; Peripheral Vascular Access Devices2) By Application: Drug Administration; Fluid And Nutrition Administration; Blood Transfusion; Diagnostics And Testing
3) By End User: Hospitals; Clinics; Ambulatory Care Centers; Other End Users
Subsegments:
1) By Central Vascular Access Devices: Central Venous Catheters (CVC); Peripherally Inserted Central Catheters (PICC); Implantable Ports2) By Peripheral Vascular Access Devices: Peripheral IV Catheters; Midline Catheters; Butterfly Needles
Companies Mentioned: Medtronic plc; Fresenius Medical Care AG & Co. KGaA; Becton Dickinson and Company (BD); Baxter International Inc.; Boston Scientific Corporation; Medline Industries LP; Terumo Corporation; B. Braun Melsungen AG; Teleflex Incorporated; ICU Medical Inc.; Cook Medical; Merit Medical Systems Inc.; AngioDynamics Inc.; Argon Medical Devices Inc.; Nipro Medical Corporation; pfm medical ag; Amecath Medical Technologies; Romsons Group; Medical Components Inc.; Access Vascular Inc.; Newtech Medical Devices Pvt. Ltd.; Vygon USA
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Vascular Access Devices market report include:- Medtronic plc
- Fresenius Medical Care AG & Co. KGaA
- Becton Dickinson and Company (BD)
- Baxter International Inc.
- Boston Scientific Corporation
- Medline Industries LP
- Terumo Corporation
- B. Braun Melsungen AG
- Teleflex Incorporated
- ICU Medical Inc.
- Cook Medical
- Merit Medical Systems Inc.
- AngioDynamics Inc.
- Argon Medical Devices Inc.
- Nipro Medical Corporation
- pfm medical ag
- Amecath Medical Technologies
- Romsons Group
- Medical Components Inc.
- Access Vascular Inc.
- Newtech Medical Devices Pvt. Ltd.
- Vygon USA
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 6.51 Billion |
| Forecasted Market Value ( USD | $ 8.38 Billion |
| Compound Annual Growth Rate | 6.5% |
| Regions Covered | Global |
| No. of Companies Mentioned | 23 |
